Hypertension Diagnostics (HDII) Osake Kurssi
Hypertension Diagnostics Kurssi
Viimeisten 19 vuoden aikana Hypertension Diagnosticsn liikevaihto kasvoi 12,2 % vuodessa ja ylsi 3,79 M USD:een. Osakekohtainen tulos on kasvanut 8,7 % vuodessa viimeisten 10 vuoden aikana. Hypertension Diagnosticsn nettomarginaali 86,9 % on noussut verrattuna −36,1 %:iin muutama vuosi sitten.
Hypertension Diagnostics osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Hypertension Diagnostics liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Hypertension Diagnostics -osakkeesta
The business model of Hypertension Diagnostics Inc revolves around providing innovative solutions for diagnosing and monitoring hypertension, a prevalent medical condition characterized by high blood pressure. Hypertension Diagnostics Inc develops and manufactures advanced medical devices and technologies that aid healthcare professionals in accurately assessing and managing patients' blood pressure levels. With a focus on product development and clinical research, the company aims to improve patient outcomes by offering reliable and efficient tools for hypertension diagnosis. By constantly advancing their technologies, Hypertension Diagnostics Inc strives to contribute to the overall improvement of healthcare in the field of hypertension management.
Hypertension Diagnostics Inc is primarily active in the healthcare and medical device industries.
The main competitors of Hypertension Diagnostics Inc in the market include companies like Medtronic, Omron Healthcare, and Philips Healthcare.
Hypertension Diagnostics Inc is a company specializing in the development and manufacturing of diagnostic devices to monitor hypertension. Founded in [year], the company has since established itself as a leader in the industry, providing innovative solutions to healthcare professionals worldwide. With a focus on accuracy, reliability, and patient comfort, Hypertension Diagnostics Inc has become a trusted name in the field of hypertension monitoring. Through continuous research and technological advancements, the company strives to improve the diagnosis and management of hypertension, ultimately contributing to better patient outcomes.
Hypertension Diagnostics Inc has achieved several significant milestones. The company successfully developed and introduced innovative diagnostic methods for high blood pressure detection, revolutionizing the healthcare industry. Hypertension Diagnostics Inc also received various accolades and recognition for its cutting-edge research and development. Additionally, the company established successful partnerships with renowned medical institutions and pharmaceutical companies, further bolstering its reputation and market presence. These achievements demonstrate Hypertension Diagnostics Inc's commitment to advancing hypertension diagnostics and improving patient care in the field of cardiovascular health.
Hypertension Diagnostics Inc primarily operates in the United States.
Hypertension Diagnostics Inc is a reputable company in the field of healthcare and diagnostics. The company's values and corporate philosophy revolve around commitment to high-quality patient care and innovation. Hypertension Diagnostics Inc believes in delivering accurate and reliable diagnostics solutions to effectively manage and treat hypertension. With a strong focus on research and development, the company aims to continuously improve and provide advanced medical technologies to professionals and patients worldwide. Hypertension Diagnostics Inc is dedicated to improving the quality of life for individuals with hypertension through their cutting-edge products and services.
Nykyisellä valuuttakurssilla Hypertension Diagnostics-osake noteerataan hintaan 0,00 EUR (0,00 USD).
Hypertension Diagnostics Inc. is a company that specializes in the development, production, and distribution of medical devices and diagnostic equipment for the study of hypertension and cardiovascular diseases. With over 30 years of experience in this field, Hypertension Diagnostics Inc. is an established provider of high-quality products for research institutions and clinical facilities worldwide.
Liikevaihtoa ei voida laskea Hypertension Diagnostics:lle tällä hetkellä.
Voittoa ei voida laskea Hypertension Diagnostics:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Hypertension Diagnostics:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Hypertension Diagnostics:lle tällä hetkellä.
Hypertension Diagnostics:n Eulpool-laatuscore on 2/10.
Hypertension Diagnostics:n ISIN on US44914V1044. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Hypertension Diagnostics:n WKN on 657841. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Hypertension Diagnostics:n ticker on HDII. Tämä pörssinoteeraus käytetään Hypertension Diagnostics-osakkeiden kauppaan pörssissä.
Hypertension Diagnostics osake
Hypertension Diagnostics vertaisryhmä
Hypertension Diagnostics Ticker
Hypertension Diagnostics FIGI
Kaikki tunnusluvut ja syvällinen analyysi Hypertension Diagnostics:sta
Meidän osakeanalyysimme Hypertension Diagnostics-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Hypertension Diagnostics:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: